Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
American Journal of Clinical Oncology
|
February 2, 2002
Brachytherapy for locally recurrent soft-tissue sarcoma
Nora Janjan, Christopher Crane, Marc Delclos, et al.
Cancer
|
February 25, 2003
Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index
Arthur Hung, Christopher Crane, Marc Delclos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2002
Limitations of conventional doses of chemoradiation for unresectable biliary cancer
Christopher H Crane, Kenneth O Macdonald, J N Vauthey, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2003
Chemoradiation for adenocarcinoma of the anus
Michael Papagikos, Christopher H Crane, John Skibber, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
January 30, 2004
Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma
Isabelle Bedrosian, Miguel A Rodriguez-Bigas, Barry Feig, et al.
Cancer
|
September 17, 2013
Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal
Cathy Eng, George J Chang, Y Nancy You, et al.
Diseases of the Colon and Rectum
|
January 5, 2006
Outcome after curative resection for locally recurrent rectal cancer
Isabelle Bedrosian, Geoffrey Giacco, Lee Pederson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 17, 2002
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
Christopher H Crane, James L Abbruzzese, Douglas B Evans, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
American Journal of Clinical Oncology
|
February 2, 2002
Brachytherapy for locally recurrent soft-tissue sarcoma
Nora Janjan, Christopher Crane, Marc Delclos, et al.
Cancer
|
February 25, 2003
Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index
Arthur Hung, Christopher Crane, Marc Delclos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2002
Limitations of conventional doses of chemoradiation for unresectable biliary cancer
Christopher H Crane, Kenneth O Macdonald, J N Vauthey, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2003
Chemoradiation for adenocarcinoma of the anus
Michael Papagikos, Christopher H Crane, John Skibber, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
January 30, 2004
Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma
Isabelle Bedrosian, Miguel A Rodriguez-Bigas, Barry Feig, et al.
Cancer
|
September 17, 2013
Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal
Cathy Eng, George J Chang, Y Nancy You, et al.
Diseases of the Colon and Rectum
|
January 5, 2006
Outcome after curative resection for locally recurrent rectal cancer
Isabelle Bedrosian, Geoffrey Giacco, Lee Pederson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 17, 2002
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
Christopher H Crane, James L Abbruzzese, Douglas B Evans, et al.
Page
of 1